Dynavax Technologies Net Income 2006-2020 | DVAX

Dynavax Technologies net income from 2006 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Dynavax Technologies Annual Net Income
(Millions of US $)
2019 $-156
2018 $-159
2017 $-95
2016 $-112
2015 $-107
2014 $-91
2013 $-75
2012 $-70
2011 $-49
2010 $-57
2009 $-31
2008 $-21
2007 $-60
2006 $-52
2005 $-21
Dynavax Technologies Quarterly Net Income
(Millions of US $)
2020-09-30 $4
2020-06-30 $-52
2020-03-31 $-13
2019-12-31 $-37
2019-09-30 $-37
2019-06-30 $-43
2019-03-31 $-40
2018-12-31 $-40
2018-09-30 $-41
2018-06-30 $-39
2018-03-31 $-39
2017-12-31 $-27
2017-09-30 $-22
2017-06-30 $-20
2017-03-31 $-25
2016-12-31 $-22
2016-09-30 $-35
2016-06-30 $-29
2016-03-31 $-27
2015-12-31 $-27
2015-09-30 $-30
2015-06-30 $-24
2015-03-31 $-26
2014-12-31 $-22
2014-09-30 $-30
2014-06-30 $-25
2014-03-31 $-14
2013-12-31 $-22
2013-09-30 $-16
2013-06-30 $-17
2013-03-31 $-21
2012-12-31 $-21
2012-09-30 $-18
2012-06-30 $-15
2012-03-31 $-17
2011-12-31 $-4
2011-09-30 $-15
2011-06-30 $-11
2011-03-31 $-18
2010-12-31 $-15
2010-09-30 $-5
2010-06-30 $-28
2010-03-31 $-9
2009-12-31 $-30
2009-09-30 $-10
2009-06-30 $4
2009-03-31 $5
2008-12-31 $3
2008-09-30 $-5
2008-06-30 $-6
2008-03-31 $-12
2007-12-31 $-12
2007-09-30 $-17
2007-06-30 $-18
2007-03-31 $-13
2006-12-31 $-16
2006-09-30 $-12
2006-06-30 $-15
2006-03-31 $-8
2005-12-31 $-9
2005-09-30 $-8
2005-06-30 $-9
2005-03-31 $5
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.033B $0.035B
Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development programs are based on immunostimulatory sequences which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $140.231B 9.72
Amgen (AMGN) United States $132.835B 13.85
CSL (CSLLY) Australia $98.074B 0.00
Gilead Sciences (GILD) United States $79.862B 8.99
Illumina (ILMN) United States $67.267B 102.46
Moderna (MRNA) United States $57.295B 0.00
Vertex Pharmaceuticals (VRTX) United States $56.422B 23.98
Regeneron Pharmaceuticals (REGN) United States $49.131B 16.06
Biogen (BIIB) United States $43.071B 8.61
Alexion Pharmaceuticals (ALXN) United States $33.964B 13.23
BeiGene (BGNE) Cayman Islands $30.635B 0.00
Seagen (SGEN) United States $28.084B 48.14
BioNTech SE (BNTX) Germany $27.490B 0.00
Genmab (GMAB) Denmark $23.026B 32.23
Exact Sciences (EXAS) United States $22.797B 0.00
Genmab (GNMSF) Denmark $21.930B 5.20
Horizon Therapeutics Public (HZNP) Ireland $21.073B 24.55
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.393B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.919B 57.05
Alnylam Pharmaceuticals (ALNY) United States $17.736B 0.00
Incyte (INCY) United States $17.722B 0.00
Guardant Health (GH) United States $16.220B 0.00
ARGENX SE-ADR (ARGX) Netherlands $15.949B 0.00
Novavax (NVAX) United States $15.275B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.125B 100.39
Bio-Techne Corp (TECH) United States $14.538B 83.26
QIAGEN (QGEN) Netherlands $11.711B 23.92
Repligen (RGEN) United States $11.344B 129.87
Mirati Therapeutics (MRTX) United States $10.202B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $10.071B 0.00
Ultragenyx Pharmaceutical (RARE) United States $9.556B 0.00
Vir Biotechnology (VIR) United States $8.330B 0.00
Fate Therapeutics (FATE) United States $8.312B 0.00
Acceleron Pharma (XLRN) United States $8.241B 0.00
Ascendis Pharma (ASND) Denmark $8.218B 0.00
Denali Therapeutics (DNLI) United States $8.006B 0.00
Adaptive Biotechnologies (ADPT) United States $7.986B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.741B 0.00
Exelixis (EXEL) United States $7.070B 64.74
Halozyme Therapeutics (HALO) United States $6.955B 57.17
Twist Bioscience (TWST) United States $6.918B 0.00
Sarepta Therapeutics (SRPT) United States $6.652B 0.00
NeoGenomics (NEO) United States $6.033B 776.29
Blueprint Medicines (BPMC) United States $5.668B 18.66
Beam Therapeutics (BEAM) United States $5.624B 0.00
Galapagos (GLPG) Belgium $5.537B 0.00
Certara (CERT) United States $5.516B 0.00
Emergent Biosolutions (EBS) United States $5.266B 12.59
SWEDISH ORP BIO (BIOVF) Sweden $5.010B 15.76
Arena Pharmaceuticals (ARNA) United States $4.833B 0.00
China Biologic Products (CBPO) China $4.716B 30.56
Reata Pharmaceuticals (RETA) United States $4.310B 0.00
I-Mab (IMAB) China $4.172B 0.00
Insmed (INSM) United States $4.078B 0.00
Intellia Therapeutics (NTLA) United States $3.765B 0.00
Legend Biotech (LEGN) United States $3.729B 0.00
Arvinas (ARVN) United States $3.686B 0.00
NantKwest (NK) United States $3.559B 0.00
MorphoSys AG (MOR) Germany $3.398B 123.00
Alkermes (ALKS) Ireland $3.166B 0.00
Editas Medicine (EDIT) United States $3.116B 0.00
Amicus Therapeutics (FOLD) United States $3.098B 0.00
Sorrento Therapeutics (SRNE) United States $3.075B 0.00
Global Blood Therapeutics (GBT) United States $3.040B 0.00
Intra-Cellular Therapies (ITCI) United States $3.033B 0.00
Viela Bio (VIE) United States $2.907B 0.00
Amarin (AMRN) Ireland $2.838B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.492B 0.00
PHARMA MAR SA (PHMMF) Spain $2.445B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.413B 19.97
Ligand Pharmaceuticals (LGND) United States $2.353B 46.02
Genetron Holdings (GTH) China $2.296B 0.00
Arcus Biosciences (RCUS) United States $2.294B 0.00
Myriad Genetics (MYGN) United States $2.264B 0.00
Vericel (VCEL) United States $2.246B 989.00
Inovio Pharmaceuticals (INO) United States $2.244B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.103B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.970B 0.00
NGM Biopharmaceuticals (NGM) United States $1.967B 0.00
Heska (HSKA) United States $1.960B 0.00
Zymeworks (ZYME) Canada $1.847B 0.00
Seres Therapeutics (MCRB) United States $1.807B 0.00
Sangamo Therapeutics (SGMO) United States $1.771B 0.00
Frequency Therapeutics (FREQ) United States $1.767B 0.00
Revance Therapeutics (RVNC) United States $1.742B 0.00
Scholar Rock Holding (SRRK) United States $1.726B 0.00
Bluebird Bio (BLUE) United States $1.720B 0.00
Bionano Genomics (BNGO) United States $1.714B 0.00
Antibe Therapeutics (ATBPF) Canada $1.680B 0.00
Castle Biosciences (CSTL) United States $1.677B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.675B 0.00
UniQure (QURE) Netherlands $1.667B 0.00
Precigen (PGEN) United States $1.589B 0.00
REGENXBIO (RGNX) United States $1.533B 0.00
Travere Therapeutics (TVTX) United States $1.529B 0.00
Alector (ALEC) United States $1.512B 0.00
Cytokinetics (CYTK) United States $1.469B 0.00
Pliant Therapeutics (PLRX) United States $1.421B 0.00
Nurix Therapeutics (NRIX) United States $1.409B 0.00
MannKind (MNKD) United States $1.391B 0.00
Zealand Pharma (ZEAL) Denmark $1.378B 0.00
Codexis (CDXS) United States $1.357B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.351B 0.00
Mersana Therapeutics (MRSN) United States $1.316B 0.00
Adverum Biotechnologies (ADVM) United States $1.295B 0.00
Northwest Biotherapeutics (NWBO) United States $1.249B 0.00
Zealand Pharma (ZLDPF) Denmark $1.203B 0.00
Coherus BioSciences (CHRS) United States $1.169B 9.60
Athenex (ATNX) United States $1.134B 0.00
Mesoblast (MESO) Australia $1.120B 0.00
MiMedx (MDXG) United States $1.114B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.113B 47.16
Celldex Therapeutics (CLDX) United States $1.098B 0.00
Morphic Holding (MORF) United States $1.086B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.076B 0.00
Avid Bioservices (CDMO) United States $1.055B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $1.050B 0.00
Epizyme (EPZM) United States $1.037B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.005B 0.00
Cara Therapeutics (CARA) United States $0.988B 0.00
Five Prime Therapeutics (FPRX) United States $0.978B 0.00
Protagonist Therapeutics (PTGX) United States $0.968B 0.00
G1 THERAPEUTICS (GTHX) United States $0.956B 0.00
Cellectis S.A (CLLS) France $0.955B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.944B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.939B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.927B 0.00
Prothena (PRTA) Ireland $0.916B 0.00
Sutro Biopharma (STRO) United States $0.889B 0.00
Pharming Group (PHGUF) Netherlands $0.851B 22.67
VBI Vaccines (VBIV) United States $0.838B 0.00
Kadmon Holdings (KDMN) United States $0.833B 0.00
Agenus (AGEN) United States $0.795B 0.00
Pandion Therapeutics (PAND) United States $0.757B 0.00
Cel-Sci (CVM) United States $0.744B 0.00
AnaptysBio (ANAB) United States $0.724B 0.00
Compugen (CGEN) Israel $0.709B 0.00
ALBIREO PHARMA (ALBO) United States $0.700B 0.00
Starpharma Holdings (SPHRY) Australia $0.698B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.675B 0.00
Merus (MRUS) Netherlands $0.657B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.643B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.623B 0.00
DBV Technologies S.A (DBVT) France $0.611B 0.00
MeiraGTx Holdings (MGTX) United States $0.609B 0.00
Precision BioSciences (DTIL) United States $0.604B 0.00
ChromaDex (CDXC) United States $0.602B 0.00
Geron (GERN) United States $0.587B 0.00
Curis (CRIS) United States $0.584B 0.00
AC Immune SA (ACIU) Switzerland $0.575B 0.00
Clovis Oncology (CLVS) United States $0.548B 0.00
AquaBounty Technologies (AQB) United States $0.545B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.542B 0.00
Gritstone Oncology (GRTS) United States $0.535B 0.00
CorMedix Inc (CRMD) United States $0.531B 0.00
Neoleukin Therapeutics (NLTX) United States $0.530B 0.00
Syros Pharmaceuticals (SYRS) United States $0.527B 0.00
Amryt Pharma (AMYT) United Kingdom $0.527B 0.00
Spero Therapeutics (SPRO) United States $0.522B 0.00
AMMO (POWW) United States $0.512B 0.00
Anika Therapeutics (ANIK) United States $0.504B 68.21
Kala Pharmaceuticals (KALA) United States $0.501B 0.00
Affimed (AFMD) Germany $0.483B 0.00
WAVE Life Sciences (WVE) Singapore $0.471B 0.00
Puma Biotechnology (PBYI) United States $0.450B 0.00
BioDelivery Sciences (BDSI) United States $0.448B 21.09
Selecta Biosciences (SELB) United States $0.447B 0.00
UROGEN PHARMA (URGN) United States $0.447B 0.00
Opthea (OPT) Australia $0.446B 0.00
Athersys (ATHX) United States $0.445B 0.00
Verastem (VSTM) United States $0.436B 0.00
IBio (IBIO) United States $0.434B 0.00
XOMA (XOMA) United States $0.409B 0.00
Cue Biopharma (CUE) United States $0.405B 0.00
Oncobiologics (OTLK) United States $0.397B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.392B 0.00
Arbutus Biopharma (ABUS) United States $0.375B 0.00
Forte Biosciences (FBRX) United States $0.374B 0.00
CytomX Therapeutics (CTMX) United States $0.372B 0.00
ANI Pharmaceuticals (ANIP) United States $0.368B 9.36
Lineage Cell Therapeutics (LCTX) United States $0.367B 0.00
Cardiff Oncology (CRDF) United States $0.363B 0.00
Fortress Biotech (FBIO) United States $0.363B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.359B 0.00
Trevena (TRVN) United States $0.352B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.350B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.349B 0.00
Innate Pharma S.A (IPHA) France $0.343B 0.00
NextCure (NXTC) United States $0.325B 0.00
Bellus Health (BLU) Canada $0.312B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.308B 0.00
Theratechnologies (THTX) Canada $0.296B 0.00
Cerecor (CERC) United States $0.291B 0.00
Kamada (KMDA) Israel $0.289B 16.64
PDL BioPharma (PDLI) United States $0.282B 0.00
OSMOTICA PHARM (OSMT) United States $0.259B 0.00
HOOKIPA Pharma (HOOK) United States $0.257B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.250B 0.00
Voyager Therapeutics (VYGR) United States $0.247B 6.34
TELA Bio (TELA) United States $0.245B 0.00
Applied Genetic Technologies (AGTC) United States $0.241B 0.00
Aptinyx (APTX) United States $0.240B 0.00
ADMA Biologics Inc (ADMA) United States $0.234B 0.00
Checkpoint Therapeutics (CKPT) United States $0.231B 0.00
Strongbridge Biopharma (SBBP) United States $0.229B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.225B 0.00
Abeona Therapeutics (ABEO) United States $0.217B 0.00
VolitionRX (VNRX) United States $0.213B 0.00
Pluristem Therapeutics (PSTI) Israel $0.213B 0.00
Exicure (XCUR) United States $0.210B 0.00
Eton Pharmaceuticals (ETON) United States $0.210B 0.00
Protalix BioTherapeutics (PLX) Israel $0.205B 0.00
GENFIT S.A (GNFT) France $0.201B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Palatin Technologies (PTN) United States $0.196B 0.00
VTv Therapeutics (VTVT) United States $0.187B 0.00
Kindred Biosciences (KIN) United States $0.187B 0.00
Nicox SA (NICXF) France $0.184B 0.00
Seelos Therapeutics (SEEL) United States $0.178B 0.00
DiaMedica Therapeutics (DMAC) United States $0.176B 0.00
Evogene (EVGN) Israel $0.173B 0.00
Orgenesis (ORGS) United States $0.172B 355.00
Clearside Biomedical (CLSD) United States $0.169B 0.00
Cogent Biosciences (COGT) United States $0.165B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.158B 0.00
Liminal BioSciences (LMNL) Canada $0.158B 0.00
Dyadic (DYAI) United States $0.157B 0.00
Idera Pharmaceuticals (IDRA) United States $0.155B 0.00
Biofrontera AG (BFRA) Germany $0.153B 0.00
Enzo Biochem (ENZ) United States $0.147B 0.00
Aptevo Therapeutics (APVO) United States $0.146B 0.00
Aytu Bioscience (AYTU) United States $0.144B 0.00
Liquidia Technologies (LQDA) United States $0.143B 0.00
Cyclerion Therapeutics (CYCN) United States $0.143B 0.00
CytRx (CYTR) United States $0.143B 0.00
Synlogic (SYBX) United States $0.140B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.134B 0.00
Catalyst Biosciences (CBIO) United States $0.134B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.131B 0.00
TRACON Pharmaceuticals (TCON) United States $0.129B 0.00
Beyond Air (XAIR) United States $0.126B 0.00
Lumos Pharma (LUMO) United States $0.122B 0.00
PHASEBIO PHARMA (PHAS) United States $0.121B 0.00
ARAVIVE, INC (ARAV) United States $0.118B 0.00
Cocrystal Pharma (COCP) United States $0.118B 0.00
Advaxis (ADXS) United States $0.113B 0.00
Prima BioMed (IMMP) Australia $0.110B 0.00
Celyad SA (CYAD) Belgium $0.110B 0.00
Novogen (KZIA) Australia $0.109B 0.00
Ecology Coatings (ABVC) United States $0.107B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.107B 0.00
Cidara Therapeutics (CDTX) United States $0.107B 0.00
Stealth BioTherapeutics (MITO) United States $0.101B 45.50
Organovo Holdings (ONVO) United States $0.099B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.096B 0.00
Vaccinex (VCNX) United States $0.094B 0.00
Vascular Biogenics (VBLT) Israel $0.094B 0.00
Adocia (ADOCY) France $0.092B 0.00
Windtree Therapeutics (WINT) United States $0.089B 0.00
AEterna Zentaris (AEZS) United States $0.089B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.086B 0.00
Celsion (CLSN) United States $0.085B 0.00
Purple Biotech (PPBT) Israel $0.084B 0.00
Cleveland BioLabs (CBLI) United States $0.078B 0.00
AnPac Bio-Medical Science (ANPC) China $0.077B 0.00
Edesa Biotech (EDSA) Canada $0.071B 0.00
Genetic Technologies (GENE) Australia $0.069B 0.00
Emmaus Life Sciences (EMMA) United States $0.069B 0.00
ARIDIS PHARMACT (ARDS) United States $0.065B 0.00
Pulmatrix (PULM) United States $0.060B 0.00
Enveric Biosciences (ENVB) United States $0.059B 0.00
Soligenix (SNGX) United States $0.057B 0.00
Appili Therapeutics (APLIF) Canada $0.056B 0.00
BioCardia (BCDA) United States $0.055B 0.00
Happiness Biotech Group (HAPP) China $0.055B 0.00
Acorda Therapeutics (ACOR) United States $0.051B 0.00
ATyr Pharma (LIFE) United States $0.049B 0.00
Yumanity Therapeutics (YMTX) United States $0.048B 0.00
Alimera Sciences (ALIM) United States $0.046B 0.00
AIkido Pharma (AIKI) United States $0.046B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.046B 0.00
Prana Biotechnology (ATHE) Australia $0.040B 0.00
IMMURON (IMRN) Australia $0.040B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.036B 0.00
Lexaria Bioscience (LEXX) Canada $0.033B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.031B 0.00
Seneca Biopharma (SNCA) United States $0.026B 0.00
Timber Pharmaceuticals (TMBR) United States $0.025B 0.00
Titan Pharmaceuticals (TTNP) United States $0.025B 0.00
GeoVax Labs (GOVX) United States $0.025B 0.00
ThermoGenesis Holdings (THMO) United States $0.025B 0.00
Benitec Biopharma (BNTC) United States $0.019B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
Cyclo Therapeutics (CYTH) United States $0.015B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00